Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT) (N-Term) anticorps
Aperçu rapide pour Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT) (N-Term) anticorps (ABIN7840877)
Antigène
Voir toutes Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- Rabbit polyclonal antibody to LRTOMT
-
Specificité
- Recognizes endogenous levels of LRTOMT protein.
-
Purification
- The antibody was purified by immunogen affinity chromatography.
-
Immunogène
- KLH-conjugated synthetic peptide encompassing a sequence within the N-terminal region of human LRTOMT. The exact sequence is proprietary.
-
-
-
-
Indications d'application
- WB (1/1000 - 1/2000)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- Leucine Rich Transmembrane and 0-Methyltransferase Domain Containing (LRTOMT)
-
Autre désignation
- LRTOMT
-
Sujet
- COMT2, TOMT, Transmembrane O-methyltransferase, Catechol O-methyltransferase 2, Protein LRTOMT2
-
ID gène
- 220074
-
UniProt
- Q8WZ04
-
Pathways
- Sensory Perception of Sound
Antigène
-